New York, United States – 17 Nov, 2023 – Distinguished radiologist and thought leader, Dr. Jeff Geschwind, will be speaking at the highly anticipated Symposium on Current Issues and New Techniques in Interventional Radiology and Endovascular Therapy. The event will take place from Nov 13 to 16 in New York City.
This symposium, which gathers some of the most brilliant minds in the field of interventional radiology and endovascular therapy, promises to be a groundbreaking event. Attendees will have the unique opportunity to learn from and engage with leaders in the field of Interventional Radiology and Oncology.
Dr. Geschwind, one of the pioneers and founders of Interventional Oncology, is the Director of Oncology at USA Clinics and Oncology Centers, and the Medical Director of Oncology and Image-Guided Therapy at NAMSA the largest device-specific Clinical Research Organization in the world. Dr. Geschwind has authored nearly 300 peer-reviewed scientific manuscripts (Google Scholar H-index 84). Dr. Geschwind is known for his innovative research and contributions to the development of cutting-edge techniques in interventional oncology and endovascular therapy.
During the symposium, Dr. Geschwind will discuss the latest trends in the staging and management of patients with liver cancer and share the latest results from histotripsy for liver cancer. The session on Interventional Oncology to be held Monday November 13 will be a focal point of the entire conference and is expected to draw medical professionals from around the world.
The symposium will also feature a comprehensive program of lectures, panel discussions, and hands-on workshops led by other eminent experts in the field. Topics will encompass a wide range of critical issues and emerging techniques, fostering a platform for knowledge exchange and collaboration.
“Interventional oncology is a continuously evolving field, with numerous opportunities for improving patient outcomes and advancing medical practice,” said Dr. Geschwind. “This symposium offers an unparalleled chance to explore new therapeutic options and to collaborate with fellow professionals who are driving the field forward.”
Medical practitioners, researchers, and students who are interested in the latest advancements in interventional radiology and endovascular therapy are encouraged to attend this prestigious event. With its commitment to excellence, the Symposium on Current Issues and New Techniques in Interventional Radiology and Endovascular Therapy is poised to be a catalyst for innovation and the future of patient care.
To register for the symposium or obtain additional information, please visit www.AIMsymposium.org or contact https://jeffgeschwind.com.
About Dr. Jeff Geschwind:
Dr. Jeff Geschwind is a distinguished clinician/scientist and interventional radiologist, Director of Oncology at USA Clinics Group, and a Medical Director of Oncology and Image-Guided Therapy at NAMSA, New York. He is renowned for his pioneering work in the new field of Interventional Oncology and extensive contributions to interventional radiology.
Media Contact
Company Name: Jeff Geschwind
Contact Person: Jeff Geschwind
Email: Send Email
Country: United States
Website: www.jeffgeschwind.com